Dr. Pritchard is a Professor in the Department of Laboratory Medicine at the University of Washington (UW) in Seattle. He also serves as Program Director for Cancer Diagnostics for the Brotman Baty Institute for Precision Medicine, and Co-Director of the Genetics and Solid Tumors Laboratory at the University of Washington Medical Center, a facility that services the Fred Hutchinson Cancer Center. Dr. Pritchard also undertook his graduate and medical training at the University of Washington. The Pritchard Laboratory focuses on oncology molecular diagnostics, particularly the source and utility of cell-free nucleic acid biomarkers in blood, and the development of innovative molecular diagnostics for the identification of DNA repair gene mutations that can guide therapeutic decision-making. His clinical work focuses on applications of next-generation sequencing gene panels for cancer risk assessment and precision treatment. He has led the development and implementation of the ColoSeq™ Lynch and Polyposis Syndrome Panel and UW-OncoPlex™ Cancer Gene Panel, both of which are in current clinical use for cancer patients and their families.
2020 Clarivate highly cited researcher. 2021 recipient of the C2 Catalyst for Precision Medicine Award.